Study of Human Placenta-derived Cells (PDA001) to Evaluate the Safety and Effectiveness for Patients With Active Rheumatoid Arthritis
Clinical trial NCT01261403 · TERMINATED
Trial details
- NCT number
- NCT01261403
- Sponsor
- Celularity Incorporated
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-12-01
- Primary completion
- 2012-02-01
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.